Immunosuppression for heart transplantation: where are we now? - Wikidata - awgldk - TriplyDB

Immunosuppression for heart transplantation: where are we now?

Immunosuppression for heart transplantation: where are we now?

http://www.wikidata.org/entity/Q36433573

about

Mammalian target of rapamycin inhibitors for heart transplant patients Immunosuppressive T-cell antibody induction for heart transplant recipients Immunosuppressive T-cell antibody induction therapy for heart transplant recipients Mammalian target of rapamycin inhibitors for heart transplant patients Bioartificial heart: a human-sized porcine model--the way ahead.Cellular and Functional Imaging of Cardiac Transplant Rejection.Immune Tolerance for Autoimmune Disease and Cell Transplantation Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions.Postoperative care of the transplanted patient Immunosuppression following heart transplantation: prospects and challenges.Immunosuppression and adult heart transplantation: emerging therapies and opportunities.Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.Perfusion-Decellularization of Porcine Lung and Trachea for Respiratory Bioengineering.

P2860

Q24194002-D3A7C1CE-70F9-417F-BC8E-8FC52C94CC4B Q24202021-670930DF-9C65-4B0D-9633-38D76C68CC21 Q24234318-15FBCB52-87E1-4DF7-A337-63905B4437B7 Q26470671-994FC835-54BE-4F9C-BCE4-5013ACF44D22 Q34445550-6971EA87-99C5-4448-8FD5-5A8C91C9F194 Q34606815-2E86C32D-8CE3-4B0C-B7DE-F4126E59D9A8 Q37099107-060339CB-11E2-4076-B0FE-344A505131DA Q37876951-92D86BCA-52F6-48DB-A39F-5353892D4D55 Q38006699-96DEC5B7-74B7-4D3B-A14E-1E26701EF510 Q38184649-3966BF03-6191-4018-B75F-79A437E1F6CC Q39029380-6163CB40-18CF-4CA2-83BC-FD617F309E9C Q42378867-53DE4B2F-6268-4E27-ADE8-C34028121902 Q51638478-0AFC293A-2939-48E9-A34A-55AD7BDA05FE

P2860

Immunosuppression for heart transplantation: where are we now?

http://www.wikidata.org/entity/Q36433573

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Immunosuppression for heart transplantation: where are we now?

@ast

Immunosuppression for heart transplantation: where are we now?

@en

type

label

Immunosuppression for heart transplantation: where are we now?

@ast

Immunosuppression for heart transplantation: where are we now?

@en

prefLabel

Immunosuppression for heart transplantation: where are we now?

@ast

Immunosuppression for heart transplantation: where are we now?

@en

P1433

Q36433573-9DAE77C6-E081-42C8-97B9-C30717F8650C

P1476

Q36433573-BAB6692D-1FB8-48C2-B0AA-509180687824

P2093

Q36433573-0A59B314-AEE3-4352-8157-6753C3D863B3

P2860

Q36433573-0CC7BECB-3A58-4DE6-9167-65C998EC465E

Q36433573-0CF43C63-68BE-4691-9711-603F210EB893

Q36433573-0E661BF3-24A0-40A4-80F5-9B29168E6682

Q36433573-1EB5E5D1-FF50-405F-B7E8-CD0BEC686FA0

Q36433573-26A00A66-B2B3-4827-817E-3C398AFC8B58

Q36433573-291BC92C-B600-40D2-9BB3-5F688A17A514

Q36433573-2CA3A73A-2322-46D9-BC4F-08189DBE17F5

Q36433573-38C4CDCE-853D-408B-A0D7-0D36B4F3983C

Q36433573-406D2A18-B939-4E68-ADCF-79C016AC467D

Q36433573-416535F3-8DEA-462F-B655-BB0EBAF64CD4

P304

Q36433573-51795B5A-060E-4994-BA11-9BF24BFF82E7

P31

Q36433573-BB842C70-62F8-46B3-BBE5-120E83673B40

P356

Q36433573-9B43F843-DBE0-4211-B03E-C30A6DBE5BD4

P433

Q36433573-6EAFB74C-3B9C-4234-B1F7-AF7CD3A74DFA

P478

Q36433573-DA84E0B9-40B5-4F2E-9A5E-404F22B7B1C3

P50

Q36433573-A1764BCA-7D90-42C7-A6BA-2D4469389BAA

P577

Q36433573-360A8DF4-B30A-4B81-8B8C-70F25D8229AD

P698

Q36433573-B46C97C8-85C9-4159-BFB3-430F70990D3A

P921

Q36433573-EE7983FF-727B-41FE-A42D-FC11516B70AC

P356

P1433

Nature Clinical Practice Cardiovascular Medicine

P1476

Immunosuppression for heart transplantation: where are we now?

@en

P2093

Jignesh K Patel

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation.

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

Clinical trial of FK 506 immunosuppression in adult cardiac transplantation.

Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.

Experiences with leflunomide in solid organ transplantation.

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

Simvastatin initiated early after heart transplantation: 8-year prospective experience.

Sirolimus therapy in cardiac transplantation.

Statins in solid organ transplantation: is there an immunosuppressive effect?

P304

203-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPCARDIO0510

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Jon A Kobashigawa

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16568129

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression